Destabilization of the colicin E9 Endonuclease domain by interaction with negatively charged phospholipids: implications for colicin translocation into bacteria.
We have shown previously that the 134-residue endonuclease domain of the bacterial cytotoxin colicin E9 (E9 DNase) forms channels in planar lipid bilayers (Mosbahi, K., Lemaître, C., Keeble, A. H., Mobasheri, H., Morel, B., James, R., Moore, G. R., Lea, E. J., and Kleanthous, C. (2002) Nat. Struct. Biol. 9, 476-484). It was proposed that the E9 DNase mediates its own translocation across the cytoplasmic membrane and that the formation of ion channels is essential to this process. Here we describe changes to the structure and stability of the E9 DNase that accompany interaction of the protein with phospholipid vesicles. Formation of the protein-lipid complex at pH 7.5 resulted in a red-shift of the intrinsic protein fluorescence emission maximum (lambda(max)) from 333 to 346 nm. At pH 4.0, where the E9 DNase lacks tertiary structure but retains secondary structure, DOPG induced a blue-shift in lambda(max), from 354 to 342 nm. Changes in lambda(max) were specific for anionic phospholipid vesicles at both pHs, suggesting electrostatics play a role in this association. The effects of phospholipid were negated by Im9 binding, the high affinity, acidic, exosite inhibitor protein, but not by zinc, which binds at the active site. Fluorescence-quenching experiments further demonstrated that similar protein-phospholipid complexes are formed regardless of whether the E9 DNase is initially in its native conformation. Consistent with these observations, chemical and thermal denaturation data as well as proteolytic susceptibility experiments showed that association with negatively charged phospholipids destabilize the E9 DNase. We suggest that formation of a destabilizing protein-lipid complex pre-empts channel formation by the E9 DNase and constitutes the initial step in its translocation across the Escherichia coli inner membrane.
Mosbahi
Khédidja
K
Department of Biology, University of York, York YO10 5YW, United Kingdom.
Walker
Daniel
D
Lea
Edward
E
Moore
Geoffrey R
GR
James
Richard
R
Kleanthous
Colin
C
D020106:Acrylamide / Q000494:pharmacology; D002942:Circular Dichroism; D003087:Colicins / Q000737:chemistry*; D003593:Cytoplasm / Q000378:metabolism; D003851:Deoxyribonucleases / Q000737:chemistry; D004220:Disulfides; D004305:Dose-Response Relationship, Drug; D004720:Endonucleases / Q000737:chemistry*; D004926:Escherichia coli / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007477:Ions; D008024:Ligands; D008051:Lipid Bilayers / Q000737:chemistry; D008055:Lipids / Q000737:chemistry; D010743:Phospholipids / Q000737:chemistry*; D011485:Protein Binding; D011487:Protein Conformation; D017434:Protein Structure, Tertiary; D021381:Protein Transport; D013050:Spectrometry, Fluorescence; D055672:Static Electricity; D013696:Temperature; D014508:Urea / Q000494:pharmacology
D003087:Colicins; D004220:Disulfides; D007477:Ions; D008024:Ligands; D008051:Lipid Bilayers; D008055:Lipids; D010743:Phospholipids; D020106:Acrylamide; D014508:Urea; D003851:Deoxyribonucleases; D004720:Endonucleases